Your browser doesn't support javascript.
loading
Global siRNA Screen Reveals Critical Human Host Factors of SARS-CoV-2 Multicycle Replication.
Yin, Xin; Pu, Yuan; Yuan, Shuofeng; Pache, Lars; Churas, Christopher; Weston, Stuart; Riva, Laura; Simons, Lacy M; Cisneros, William J; Clausen, Thomas; De Jesus, Paul D; Kim, Ha Na; Fuentes, Daniel; Whitelock, John; Esko, Jeffrey; Lord, Megan; Mena, Ignacio; García-Sastre, Adolfo; Hultquist, Judd F; Frieman, Matthew B; Ideker, Trey; Pratt, Dexter; Martin-Sancho, Laura; Chanda, Sumit K.
Afiliación
  • Yin X; State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China.
  • Pu Y; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, USA.
  • Yuan S; Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.
  • Pache L; Immunity and Pathogenesis Program, Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
  • Churas C; Department of Medicine, University of California San Diego, La Jolla, USA.
  • Weston S; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, USA.
  • Riva L; Calibr-Skaggs at Scripps Research Institute, La Jolla, USA.
  • Simons LM; Division of Infectious Diseases, Departments of Medicine and Microbiology-Immunology, Northwestern University Feinberg School of Medicine, Chicago, USA.
  • Cisneros WJ; Division of Infectious Diseases, Departments of Medicine and Microbiology-Immunology, Northwestern University Feinberg School of Medicine, Chicago, USA.
  • Clausen T; Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, USA.
  • De Jesus PD; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, USA.
  • Kim HN; Molecular Surface Interaction Laboratory, Mark Wainwright Analytical Centre, UNSW Sydney, Sydney, New South Wales, Australia.
  • Fuentes D; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, USA.
  • Whitelock J; Molecular Surface Interaction Laboratory, Mark Wainwright Analytical Centre, UNSW Sydney, Sydney, New South Wales, Australia.
  • Esko J; Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, USA.
  • Lord M; Molecular Surface Interaction Laboratory, Mark Wainwright Analytical Centre, UNSW Sydney, Sydney, New South Wales, Australia.
  • Mena I; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, USA.
  • García-Sastre A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, USA; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, USA;
  • Hultquist JF; Division of Infectious Diseases, Departments of Medicine and Microbiology-Immunology, Northwestern University Feinberg School of Medicine, Chicago, USA.
  • Frieman MB; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, USA.
  • Ideker T; Department of Medicine, University of California San Diego, La Jolla, USA.
  • Pratt D; Department of Computer Science and Engineering, University of California San Diego, La Jolla, USA.
  • Martin-Sancho L; Department of Medicine, University of California San Diego, La Jolla, USA.
  • Chanda SK; Department of Infectious Disease, Imperial College London, London, United Kingdom.
bioRxiv ; 2024 Jul 10.
Article en En | MEDLINE | ID: mdl-39026801
ABSTRACT
Defining the subset of cellular factors governing SARS-CoV-2 replication can provide critical insights into viral pathogenesis and identify targets for host-directed antiviral therapies. While a number of genetic screens have previously reported SARS-CoV-2 host dependency factors, these approaches relied on utilizing pooled genome-scale CRISPR libraries, which are biased towards the discovery of host proteins impacting early stages of viral replication. To identify host factors involved throughout the SARS-CoV-2 infectious cycle, we conducted an arrayed genome-scale siRNA screen. Resulting data were integrated with published datasets to reveal pathways supported by orthogonal datasets, including transcriptional regulation, epigenetic modifications, and MAPK signalling. The identified proviral host factors were mapped into the SARS-CoV-2 infectious cycle, including 27 proteins that were determined to impact assembly and release. Additionally, a subset of proteins were tested across other coronaviruses revealing 17 potential pan-coronavirus targets. Further studies illuminated a role for the heparan sulfate proteoglycan perlecan in SARS-CoV-2 viral entry, and found that inhibition of the non-canonical NF-kB pathway through targeting of BIRC2 restricts SARS-CoV-2 replication both in vitro and in vivo. These studies provide critical insight into the landscape of virus-host interactions driving SARS-CoV-2 replication as well as valuable targets for host-directed antivirals.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: BioRxiv Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: BioRxiv Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos